280 related articles for article (PubMed ID: 33991218)
1. The effect of mindfulness-based stress reduction on the urinary microbiome in interstitial cystitis.
Shatkin-Margolis A; White J; Jedlicka AE; Tam T; Hill A; Yeung J; Crisp CC; Pauls RN
Int Urogynecol J; 2022 Mar; 33(3):665-671. PubMed ID: 33991218
[TBL] [Abstract][Full Text] [Related]
2. Mindfulness-based stress reduction as a novel treatment for interstitial cystitis/bladder pain syndrome: a randomized controlled trial.
Kanter G; Komesu YM; Qaedan F; Jeppson PC; Dunivan GC; Cichowski SB; Rogers RG
Int Urogynecol J; 2016 Nov; 27(11):1705-1711. PubMed ID: 27116196
[TBL] [Abstract][Full Text] [Related]
3. Urinary Microbiome and Cytokine Levels in Women With Interstitial Cystitis.
Abernethy MG; Rosenfeld A; White JR; Mueller MG; Lewicky-Gaupp C; Kenton K
Obstet Gynecol; 2017 Mar; 129(3):500-506. PubMed ID: 28178051
[TBL] [Abstract][Full Text] [Related]
4. Interstitial cystitis/bladder pain syndrome and recurrent urinary tract infection and the potential role of the urinary microbiome.
Bhide A; Tailor V; Khullar V
Post Reprod Health; 2020 Jun; 26(2):87-90. PubMed ID: 32627695
[TBL] [Abstract][Full Text] [Related]
5. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
[TBL] [Abstract][Full Text] [Related]
6. The overlap and distinction of self-reported symptoms between interstitial cystitis/bladder pain syndrome and overactive bladder: a questionnaire based analysis.
Lai HH; Vetter J; Jain S; Gereau RW; Andriole GL
J Urol; 2014 Dec; 192(6):1679-85. PubMed ID: 24907443
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States.
Berry SH; Elliott MN; Suttorp M; Bogart LM; Stoto MA; Eggers P; Nyberg L; Clemens JQ
J Urol; 2011 Aug; 186(2):540-4. PubMed ID: 21683389
[TBL] [Abstract][Full Text] [Related]
8. The bacterial microbiota of Hunner lesion interstitial cystitis/bladder pain syndrome.
Nickel JC; Ehrlich GD; Krol JE; Ahmed A; Sen B; Bhat A; Mell JC; Doiron RC; Kelly KL; Earl JP
BJU Int; 2022 Jan; 129(1):104-112. PubMed ID: 34143561
[TBL] [Abstract][Full Text] [Related]
9. Urinary microbiome in uncomplicated and interstitial cystitis: is there any similarity?
Yıldırım S; Shoskes D; Kulkarni S; Laguna P
World J Urol; 2020 Nov; 38(11):2721-2731. PubMed ID: 32006175
[TBL] [Abstract][Full Text] [Related]
10. Detection of Bacteria in Bladder Mucosa of Adult Females.
Wolfe AJ; Rademacher DJ; Mores CR; Evans RJ; Overholt T; Halverson T; Limeira R; Matthews C; Badlani G; Brubaker L; Walker SJ
J Urol; 2023 May; 209(5):937-949. PubMed ID: 36657058
[TBL] [Abstract][Full Text] [Related]
11. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
12. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
Bosch PC
Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
[TBL] [Abstract][Full Text] [Related]
13. Comparison of an interstitial cystitis/bladder pain syndrome clinical cohort with symptomatic community women from the RAND Interstitial Cystitis Epidemiology study.
Konkle KS; Berry SH; Elliott MN; Hilton L; Suttorp MJ; Clauw DJ; Clemens JQ
J Urol; 2012 Feb; 187(2):508-12. PubMed ID: 22177158
[TBL] [Abstract][Full Text] [Related]
14. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome.
Nickel JC; Tripp DA;
J Urol; 2015 Jan; 193(1):138-44. PubMed ID: 25092637
[TBL] [Abstract][Full Text] [Related]
15. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
[TBL] [Abstract][Full Text] [Related]
16. Bladder Capacity is a Biomarker for a Bladder Centric versus Systemic Manifestation in Interstitial Cystitis/Bladder Pain Syndrome.
Walker SJ; Zambon J; Andersson KE; Langefeld CD; Matthews CA; Badlani G; Bowman H; Evans RJ
J Urol; 2017 Aug; 198(2):369-375. PubMed ID: 28202356
[TBL] [Abstract][Full Text] [Related]
17. Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study.
Chancellor MB; Bartolone SN; Veerecke A; Lamb LE
J Urol; 2018 May; 199(5):1344-1350. PubMed ID: 29225061
[TBL] [Abstract][Full Text] [Related]
18. Clinical phenotyping of women with interstitial cystitis/painful bladder syndrome: a key to classification and potentially improved management.
Nickel JC; Shoskes D; Irvine-Bird K
J Urol; 2009 Jul; 182(1):155-60. PubMed ID: 19447429
[TBL] [Abstract][Full Text] [Related]
19. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
20. The bladder microbiome and interstitial cystitis: is there a connection?
Abernethy MG; Tsuei A
Curr Opin Obstet Gynecol; 2021 Dec; 33(6):469-473. PubMed ID: 34475365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
